Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Mar-24 9:48 PM View:  | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Payment of Exercise | 56,692 | $0.69 | $39,117.50 | (4%) 1.58M to 1.53M | |
| 21-Sep-23 1:21 PM View: | Novacea, Inc. (PRTK) | 21-Sep-23 | Disposition | 68,625 | -- | -- | (100%) 68.63K to 0 | |
| 08-Aug-23 6:04 PM View: | Cidara Therapeutics, Inc. (CDTX) | 08-Aug-23 | Private Purchase | 50,000 | $0.96 | $47,885.00 | 3% 1.53M to 1.58M | |
| 29-Mar-23 5:30 PM View: | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 271,750 | -- | -- | 22% 1.25M to 1.53M | |
| 27-Mar-23 7:03 PM View: | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Market Purchase | 50,000 | $1.04 | $51,855.00 | 4% 1.2M to 1.25M | 1% |
| 23-Feb-23 2:27 PM View: | Novacea, Inc. (PRTK) | 21-Feb-23 | Sale (Planned) | 7,000 | $1.90 | $13,300.00 | (9%) 75.63K to 68.63K | |
| 09-Feb-23 9:49 PM View: | Novacea, Inc. (PRTK) | 08-Feb-23 | Grant | 20,000 | -- | -- | 36% 55.63K to 75.63K | |
| 04-Apr-22 5:09 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 573,742 | -- | -- | 75% 763.49K to 1.34M | |
| 04-Apr-22 5:09 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 140,985 | $0.83 | $117,018.00 | (11%) 1.34M to 1.2M | |
| 18-Feb-22 5:35 PM View: | Novacea, Inc. (PRTK) | 16-Feb-22 | Grant | 20,000 | -- | -- | 56% 35.63K to 55.63K | |
| 07-Jan-22 8:24 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Dec-21 | Option Exercise | 20,000 | -- | -- | 3% 743.49K to 763.49K | |
| 15-Nov-21 6:41 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Nov-21 | Market Purchase | 50,000 | $1.59 | $79,530.00 | 7% 689.49K to 739.49K | 1% |
| 19-Aug-21 4:24 PM View: | Cidara Therapeutics, Inc. (CDTX) | 19-Aug-21 | Market Purchase | 10,000 | $1.79 | $17,871.00 | 1% 679.49K to 689.49K | (< 1%) |
| 19-Aug-21 4:24 PM View: | Cidara Therapeutics, Inc. (CDTX) | 18-Aug-21 | Market Purchase | 40,000 | $1.72 | $68,884.00 | 6% 639.49K to 679.49K | 3% |
| 05-Apr-21 3:00 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-21 | Grant | 10,000 | -- | -- | 2% 625.49K to 635.49K | |
| 22-Feb-21 6:46 PM View: | Novacea, Inc. (PRTK) | 18-Feb-21 | Grant | 9,000 | -- | -- | 34% 26.63K to 35.63K | |
| 12-Nov-20 6:00 AM View: | Cidara Therapeutics, Inc. (CDTX) | 10-Nov-20 | Market Purchase | 50,000 | $2.00 | $100,015.00 | 9% 571.49K to 621.49K | 5% |
| 21-Feb-20 9:33 PM View: | Novacea, Inc. (PRTK) | 19-Feb-20 | Grant | 9,000 | -- | -- | 51% 17.63K to 26.63K | |
| 30-Jan-20 8:50 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Jan-20 | Exercise (in-the money or at-the-money) | 7,558 | $2.51 | $18,970.60 | 1% 527.65K to 535.21K | |
| 30-Jan-20 8:50 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Jan-20 | Exercise (in-the money or at-the-money) | 32,283 | $2.51 | $81,030.30 | 6% 535.21K to 567.49K | |
| 26-Sep-19 9:23 PM View: | Cidara Therapeutics, Inc. (CDTX) | 24-Sep-19 | Market Purchase | 52,500 | $1.91 | $100,102.00 | 11% 471.15K to 523.65K | 10% |
| 16-Sep-19 5:41 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-19 | Grant | 10,000 | -- | -- | 2% 461.15K to 471.15K | |
| 13-Mar-19 12:54 PM View: | Cidara Therapeutics, Inc. (CDTX) | 26-Feb-19 | Gift | 10,670 | -- | -- | 2% 467.82K to 478.49K | |
| 13-Mar-19 12:54 PM View: | Cidara Therapeutics, Inc. (CDTX) | 26-Feb-19 | Gift | 21,340 | -- | -- | (4%) 478.49K to 457.15K | |
| 28-Feb-19 7:48 PM View: | Novacea, Inc. (PRTK) | 26-Feb-19 | Grant | 7,500 | -- | -- | 74% 10.13K to 17.63K | |
| 20-Feb-19 4:45 PM View: | Novacea, Inc. (PRTK) | 15-Feb-19 | Market Sale (Planned) | 3,375 | $7.14 | $24,097.50 | (25%) 13.5K to 10.13K | (< 1%) |
| 04-Dec-18 7:08 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Nov-18 | Gift | 4,619 | -- | -- | < 1% 472.44K to 477.06K | |
| 04-Dec-18 7:08 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Nov-18 | Gift | 9,238 | -- | -- | (2%) 477.06K to 467.82K | |
| 24-May-18 5:16 PM View: | Cidara Therapeutics, Inc. (CDTX) | 23-May-18 | Private Purchase | 212,766 | $4.70 | $1,000,000.00 | 82% 259.67K to 472.44K | |
| 16-Feb-18 5:27 PM View: | Novacea, Inc. (PRTK) | 14-Feb-18 | Grant | 7,500 | -- | -- | 125% 6.0K to 13.5K | |
| 12-Sep-17 5:49 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-17 | Market Purchase | 7,350 | $6.79 | $49,906.50 | 3% 248.62K to 255.97K | (69%) |
| 07-Jun-17 4:45 PM View: | Cidara Therapeutics, Inc. (CDTX) | 05-Jun-17 | Market Purchase | 15,000 | $5.95 | $89,211.00 | 6% 233.62K to 248.62K | (65%) |
| 04-Apr-17 4:33 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-17 | Market Purchase | 12,900 | $7.75 | $99,975.00 | 6% 218.41K to 231.31K | (73%) |
| 06-Feb-17 7:19 PM View: | Novacea, Inc. (PRTK) | 02-Feb-17 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 23-May-16 4:32 PM View: | Cidara Therapeutics, Inc. (CDTX) | 20-May-16 | Market Purchase | 4,310 | $11.51 | $49,608.10 | 2% 211.49K to 215.8K | (83%) |
| 27-Nov-15 5:33 PM View: | Cidara Therapeutics, Inc. (CDTX) | 25-Nov-15 | Market Purchase | 1,300 | $15.60 | $20,280.00 | < 1% 204.79K to 206.09K | (88%) |
| 27-Nov-15 5:33 PM View: | Cidara Therapeutics, Inc. (CDTX) | 24-Nov-15 | Market Purchase | 5,400 | $14.97 | $80,838.00 | 3% 199.39K to 204.79K | (87%) |
| 21-Apr-15 3:35 PM View: | Cidara Therapeutics, Inc. (CDTX) | 20-Apr-15 | Purchase | 420 | $16.00 | $6,720.00 | < 1% 199.39K to 199.81K | |
| 13-Sep-13 7:12 PM View: | Trius Therapeutics Inc (TSRX) | 11-Sep-13 | Disposition | 210,457 | -- | -- | (100%) 210.46K to 0 | |
| 28-Mar-12 3:50 PM View: | Trius Therapeutics Inc (TSRX) | 27-Mar-12 | Option Exercise | 38,462 | $0.52 | $20,000.20 | 22% 172.0K to 210.46K | |
| 16-Dec-10 2:05 PM View: | Trius Therapeutics Inc (TSRX) | 15-Dec-10 | Option Exercise | 22,700 | $0.52 | $11,804.00 | 15% 149.29K to 172.0K | |
| 10-Aug-10 2:10 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Conversion | 5,285 | -- | -- | 4% 144.01K to 149.29K |